Ancora Advisors LLC Buys New Shares in Sotera Health Company $SHC

Ancora Advisors LLC purchased a new position in Sotera Health Company (NASDAQ:SHC - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 2,683,637 shares of the company's stock, valued at approximately $47,635,000. Sotera Health comprises 0.9% of Ancora Advisors LLC's investment portfolio, making the stock its 20th largest position. Ancora Advisors LLC owned about 0.94% of Sotera Health as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in SHC. IFP Advisors Inc lifted its position in shares of Sotera Health by 1,105.6% in the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company's stock worth $26,000 after acquiring an additional 1,371 shares during the period. Rothschild Investment LLC acquired a new stake in shares of Sotera Health during the 4th quarter worth approximately $27,000. Meeder Asset Management Inc. bought a new stake in shares of Sotera Health during the second quarter valued at approximately $37,000. Root Financial Partners LLC increased its position in shares of Sotera Health by 217.5% during the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company's stock valued at $30,000 after purchasing an additional 1,455 shares during the period. Finally, Eurizon Capital SGR S.p.A. acquired a new position in shares of Sotera Health in the fourth quarter valued at $40,000. Institutional investors own 91.03% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on SHC shares. UBS Group set a $19.00 price objective on shares of Sotera Health in a research note on Wednesday, June 24th. Barclays upped their target price on shares of Sotera Health from $19.00 to $22.00 and gave the company an "overweight" rating in a research note on Friday, August 7th. Citigroup raised their price target on shares of Sotera Health from $23.00 to $25.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. Wall Street Zen upgraded Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday. Finally, Weiss Ratings raised Sotera Health from a "hold (c)" rating to a "hold (c+)" rating in a report on Tuesday, August 11th. Eight equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $21.50.

Insider Buying and Selling

In related news, insider Michael P. Rutz sold 150,000 shares of the firm's stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $18.84, for a total value of $2,826,000.00. Following the completion of the sale, the insider owned 334,279 shares of the company's stock, valued at $6,297,816.36. This trade represents a 30.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the business's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the completion of the transaction, the chairman owned 3,969,393 shares of the company's stock, valued at $73,433,770.50. This trade represents a 17.64% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,294,515 shares of company stock worth $23,999,528 over the last quarter. 15.36% of the stock is owned by company insiders.

Sotera Health Price Performance

Sotera Health stock opened at $18.90 on Tuesday. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80. The firm has a market cap of $5.39 billion, a P/E ratio of 33.16 and a beta of 1.77. The business's fifty day moving average is $18.18 and its two-hundred day moving average is $16.41. Sotera Health Company has a 52 week low of $13.09 and a 52 week high of $19.85.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.24 by $0.02. The company had revenue of $321.38 million for the quarter, compared to analysts' expectations of $309.70 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The business's revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.20 earnings per share. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Equities research analysts forecast that Sotera Health Company will post 0.86 earnings per share for the current fiscal year.

About Sotera Health

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health Company (NASDAQ:SHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source